GlaxoSmithKline Pharmaceuticals Ltd.
-
NSE: GLAXO
-
BSE: 500660
-
Q
-
V
-
T
Quality Score
High Financial StrengthValuation Score
Mid ValuationTechnical Score
Technically NeutralBroker average target upside %
7.10 %
Low in industry
TTM PE Ratio
12.80
Below industry Median
Price to Book Ratio
8.20
High in industry
Operating Revenues Qtr Cr
802.30 Cr
High in industry
Net Profit Qtr Cr
164.60 Cr
High in industry
RSI
48.10
RSI is mid-range
MFI
38.20
MFI is mid-range
MACD
0.10
MACD above Center
MACD Signal Line
2.30
MACD above Center
30Day SMA Rs
1286.90 Rs
Price below SMA-30
50Day SMA Rs
1282.40 Rs
Price above SMA 1282.40
100Day SMA Rs
1306.80 Rs
Price below SMA-100
200Day SMA Rs
1379.10 Rs
Price below SMA-200
Promoter holding %
75.00
No change in Promoter holding
FII holding current Qtr %
2.28
FII holdings rise by 0.11%
MF holding current Qtr %
4.12
MF holdings rise by 0.30%
Institutions holding %
12.57
Institutions holding decreased by 0.1400%.
Broker Average Rating
4.00
Broker Average Rating
Broker Covering stock
2.00
2 Broker Covering stock
Broker 1Year total
7.00
7 Broker 1Year total
Broker 6M Reco downgrade
0.00
0 Broker 6M Reco downgrade
Broker 6M Reco upgrade
1.00
1 Broker 6M Reco upgrade
Broker 6M Target downgrade
3.00
3 Broker 6M Target downgrade
Broker 6M Target upgrade
1.00
1 Broker 6M Target upgrade
Momentum score
42.79
Technically Neutral
Valuation score
37.67
Mid Valuation
Quality score
76.81
High Financial Strength
Peer Comparison
All values except ratios in INR(Crores)
Stock Name | Current Price Rs | PE TTM Price To Earnings | Market Capitalization In Cr | Dividend Yield 1yr % | Net Profit Qtr Cr | Net Profit Annual Growth YoY % | Operating Revenues Qtr Cr | Revenue Growth Qtr YoY | Price To Book Value |
---|---|---|---|---|---|---|---|---|---|
GlaxoSmithKline Pharmaceuticals Ltd. | 1283.15 | 12.81 | 21737.33 | 7.01 | 164.56 | 0 | 802.3 | -1.67 | 8.16 |
Sun Pharmaceutical Industries Ltd. | 972.05 | 55.37 | 233227.35 | 1.08 | 2166.01 | 0 | 11240.97 | 13.97 | 4.56 |
Dr. Reddy's Laboratories Ltd. | 4474.95 | 20.44 | 74519.95 | 0.67 | 1243.9 | 0 | 6789.8 | 27.19 | 3.87 |
Divi's Laboratories Ltd. | 2790.65 | 30.9 | 74082.99 | 1.07 | 306.8 | 0 | 1707.68 | -31.51 | 6.31 |
Cipla Ltd. | 863.4 | 26.41 | 69689.38 | 0.57 | 800.96 | 0 | 5810.09 | 6.04 | 3.3 |
Torrent Pharmaceuticals Ltd. | 1518.6 | 61.84 | 51396.31 | 1.67 | 283 | 0 | 2491 | 18.16 | 8.63 |
Zydus Lifesciences Ltd. | 478.65 | 23.5 | 48449.14 | 0.52 | 622.9 | 0 | 4362.3 | 19.35 | 2.54 |
Abbott India Ltd. | 21491.65 | 49.13 | 45668.25 | 1.27 | 246.83 | 0 | 1326.48 | 8.34 | 16.19 |